Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation
    13.
    发明申请
    Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation 审中-公开
    含有奥泊普卡因的镇痛/止痒剂外用制剂

    公开(公告)号:US20110124727A1

    公开(公告)日:2011-05-26

    申请号:US12999195

    申请日:2009-06-12

    摘要: An analgesic/antipruritic external preparation that includes a local anesthetic, has fewer side effects, and has an excellent therapeutic effect on pain and itching of the skin is provided. The analgesic/antipruritic external preparation includes oxybuprocaine or a pharmaceutically acceptable salt thereof as an active ingredient, and the oxybuprocaine or a pharmaceutically acceptable salt thereof is contained in an amount of 0.1 to 60 wt %, more preferably 1 to 40 wt %, and most preferably 5 to 30 wt %. The analgesic/antipruritic external preparation has a dosage form as an external preparation wherein the dosage form is an ointment, a solution, a suspension, an emulsion, a lotion, a cataplasm, a tape, an aerosol, or a powder for external use.

    摘要翻译: 提供了包含局部麻醉剂的镇痛/止痒剂外用剂,副作用较少,对疼痛和皮肤瘙痒具有优异的治疗作用。 止痛/止痒剂外用制剂包括活性成分的布比卡因或其药学上可接受的盐,并且含有布比卡因或其药学上可接受的盐的含量为0.1〜60重量%,更优选为1〜40重量% 优选为5〜30重量%。 止痛/止痒外用制剂具有作为外用制剂的剂型,其中剂型为软膏剂,溶液剂,悬浮液剂,乳剂剂,洗剂剂,粘膜剂,胶带剂,气雾剂或外用粉剂。

    Therapeutic agent for hemorrhoidal disease
    16.
    发明申请
    Therapeutic agent for hemorrhoidal disease 有权
    痔疮疾病治疗剂

    公开(公告)号:US20060159711A1

    公开(公告)日:2006-07-20

    申请号:US10545910

    申请日:2004-02-17

    IPC分类号: A61K31/60 A61K9/00

    CPC分类号: A61K31/616 A61K9/0031

    摘要: An external preparation containing acetylsalicylic acid or its pharmaceutically acceptable salt as an active ingredient for treating anal diseases having therapeutic activity on hemorrhoids (internal hemorrhoid, external hemorrhoid), hemorrhoidal disease owing to anal fissure and other anal diseases together with activity on pain and pruritus.

    摘要翻译: 含有乙酰水杨酸或其药学上可接受的盐作为有效成分的外用制剂,用于治疗对痔疮具有治疗活性的肛门疾病(内痔疮,外痔疮),由于肛裂引起的痔疮疾病及其他肛门疾病以及疼痛和瘙痒的活动。